Akyol, Onat <br/><br/>
Neurotrophin-3 provides neuroprotection via TrkC receptor dependent pErk5 activation in a rat surgical brain injury model.  [electronic resource] 

 -  Experimental neurology  09 2018 
 - 82-89 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1090-2430 
<br/><br/><label>Standard No.: </label>10.1016/j.expneurol.2018.06.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Topical<br/>Animals<br/>Blood-Brain Barrier--drug effects<br/>Brain Injuries--etiology<br/>Enzyme Activation--drug effects<br/>Male<br/>Mitogen-Activated Protein Kinase 7--metabolism<br/>Neuroprotection--drug effects<br/>Neurosurgical Procedures--adverse effects<br/>Neurotrophin 3--administration & dosage<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptor, trkC--metabolism